{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:22:51Z","timestamp":1780582971968,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Projects of Beijing Natural Science Foundation","award":["No. 7232143"],"award-info":[{"award-number":["No. 7232143"]}]},{"name":"Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund","award":["L212012"],"award-info":[{"award-number":["L212012"]}]},{"name":"Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund","award":["L212012"],"award-info":[{"award-number":["L212012"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2024-154"],"award-info":[{"award-number":["BJ-2024-154"]}]},{"name":"the Shenzhen Science and Technology Innovation Committee Projects","award":["No. JCYJ20220818102817038"],"award-info":[{"award-number":["No. JCYJ20220818102817038"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202411004"],"award-info":[{"award-number":["SZSM202411004"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11387-3","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:05:47Z","timestamp":1753887947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals"],"prefix":"10.1186","volume":"25","author":[{"given":"Shana","family":"Halemubieke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudulimutailipu","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"11387_CR1","unstructured":"WHO, The global health observatory of HIV (2024). https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids. Accessed 20 September 2024."},{"issue":"7993","key":"11387_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","volume":"625","author":"A Yisimayi","year":"2024","unstructured":"Yisimayi A, Song W, Wang J, et al. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Nature. 2024;625(7993):148\u201356.","journal-title":"Nature"},{"key":"11387_CR3","doi-asserted-by":"publisher","first-page":"1129651","DOI":"10.3389\/fimmu.2023.1129651","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qiao Y, Huo Y, et al. The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: a multicenter prospective cohort study. Front Immunol. 2023;14:1129651.","journal-title":"Front Immunol"},{"issue":"5","key":"11387_CR4","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1016\/S2352-3018(21)00070-9","volume":"8","author":"J Ambrosioni","year":"2021","unstructured":"Ambrosioni J, Blanco JL, Reyes-Uruena JM, et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV. 2021;8(5):e294\u2013305.","journal-title":"Lancet HIV"},{"issue":"9","key":"11387_CR5","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s10461-024-04394-z","volume":"28","author":"R Garcia-Carretero","year":"2024","unstructured":"Garcia-Carretero R, Vazquez-Gomez O, Rodriguez-Maya B, et al. Outcomes of patients living with HIV hospitalized due to COVID-19: a 3-year nationwide study (2020\u20132022). AIDS Behav. 2024;28(9):3093\u2013102.","journal-title":"AIDS Behav"},{"key":"11387_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","volume":"73","author":"MJ Hogan","year":"2022","unstructured":"Hogan MJ, Pardi N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med. 2022;73:17\u201339.","journal-title":"Annu Rev Med"},{"issue":"12","key":"11387_CR7","first-page":"CD015477","volume":"12","author":"C Grana","year":"2022","unstructured":"Grana C, Ghosn L, Evrenoglou T, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12(12):CD015477.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"11387_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Wang H, Tian L, et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022;7(1):146.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"11387_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21(2):73\u201382.","journal-title":"Nat Rev Immunol"},{"key":"11387_CR10","unstructured":"The National Health Commission of the People\u2019s Republic of China. http:\/\/www.nhc.gov.cn\/xcs\/yqfkdt\/202103\/c2febfd04fc5498f916b1be080905771.shtml. Accessed 10 September 2024."},{"key":"11387_CR11","unstructured":"China N H C O. Issues about COVID-19 Booster Vaccination. http:\/\/www.nhc.gov.cn\/xcs\/s7847\/202111\/67a59e40580d4b4687b3ed738333f6a9.shtml. Accessed 12 September 2024."},{"key":"11387_CR12","unstructured":"The National Health Commission of the People\u2019s Republic of China. https:\/\/www.gov.cn\/xinwen\/2022-12\/07\/content_5730443.htm. Accessed 4 August 2024."},{"issue":"1","key":"11387_CR13","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1186\/s12889-023-17361-5","volume":"23","author":"R Liu","year":"2023","unstructured":"Liu R, Zhang Y, Ma J, et al. Epidemiological features of SARS-CoV-2 Omicron infection under new control strategy: a cross-sectional study of the outbreak since December 2022 in Sichuan, China. BMC Public Health. 2023;23(1):2463.","journal-title":"BMC Public Health"},{"issue":"1","key":"11387_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29395","volume":"96","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lan X, Qiao Y, et al. Safety and immunogenicity of homologous prime-boost CoronaVac vaccine in people living with HIV in China: a multicenter prospective cohort study. J Med Virol. 2024;96(1): e29395.","journal-title":"J Med Virol"},{"issue":"2","key":"11387_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29446","volume":"96","author":"H Zhan","year":"2024","unstructured":"Zhan H, Xie Y, Liu Y, et al. Omicron BA4\/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: a follow-up cohort study. J Med Virol. 2024;96(2): e29446.","journal-title":"J Med Virol"},{"issue":"9","key":"11387_CR16","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","volume":"185","author":"LB Rodda","year":"2022","unstructured":"Rodda LB, Morawski PA, Pruner KB, et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell. 2022;185(9):1588\u2013601.","journal-title":"Cell"},{"key":"11387_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.822680","volume":"9","author":"J Yang","year":"2022","unstructured":"Yang J, Yu M, Fu G, et al. COVID-19 vaccination uptake among a nationwide sample of people living with HIV during the early phase of vaccine rollout in China. Front Med (Lausanne). 2022;9: 822680.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"11387_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15585\/mmwr.mm7105a4","volume":"71","author":"JM Tesoriero","year":"2022","unstructured":"Tesoriero JM, Patterson W, Daskalakis D, et al. Notes from the field: COVID-19 vaccination among persons living with diagnosed HIV infection\u2014New York, October 2021. MMWR Morb Mortal Wkly Rep. 2022;71(5):182\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11387_CR19","unstructured":"Chinese Center for Disease Control and Prevention. Epidemic situation of novel coronavirus infection in China. https:\/\/www.chinacdc.cn\/jksj\/xgbdyq\/index_1.html. Accessed: 12th October, 2024."},{"issue":"4","key":"11387_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/v16040555","volume":"16","author":"I Ngare","year":"2024","unstructured":"Ngare I, Tan TS, Toyoda M, et al. Factors associated with neutralizing antibody responses following 2-dose and 3rd booster monovalent COVID-19 vaccination in Japanese people living with HIV. Viruses. 2024;16(4):555.","journal-title":"Viruses"},{"issue":"1","key":"11387_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28356","volume":"95","author":"Y Pan","year":"2023","unstructured":"Pan Y, Wang S, Liu G, et al. The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody. J Med Virol. 2023;95(1): e28356.","journal-title":"J Med Virol"},{"issue":"1","key":"11387_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28428","volume":"95","author":"H Zhan","year":"2023","unstructured":"Zhan H, Gao H, Liu Y, et al. Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV. J Med Virol. 2023;95(1): e28428.","journal-title":"J Med Virol"},{"issue":"1","key":"11387_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12865-024-00625-z","volume":"25","author":"AL Batchi-Bouyou","year":"2024","unstructured":"Batchi-Bouyou AL, Djontu JC, Ingoba LL, et al. Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay. BMC Immunol. 2024;25(1):43.","journal-title":"BMC Immunol"},{"issue":"2","key":"11387_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106208","volume":"89","author":"X Gong","year":"2024","unstructured":"Gong X, Peng L, Wang F, et al. Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants. J Infect. 2024;89(2): 106208.","journal-title":"J Infect"},{"issue":"1","key":"11387_CR25","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1038\/s41467-023-38892-w","volume":"14","author":"S Chalkias","year":"2023","unstructured":"Chalkias S, Harper C, Vrbicky K, et al. Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. Nat Commun. 2023;14(1):5125.","journal-title":"Nat Commun"},{"issue":"6","key":"11387_CR26","first-page":"750","volume":"51","author":"MS Islamoglu","year":"2021","unstructured":"Islamoglu MS, Cengiz M, Uysal BB, et al. Relationship between antibody levels and SARS-Cov-2 reinfection. Ann Clin Lab Sci. 2021;51(6):750\u20135.","journal-title":"Ann Clin Lab Sci"},{"key":"11387_CR27","doi-asserted-by":"publisher","first-page":"1023507","DOI":"10.3389\/fmed.2022.1023507","volume":"9","author":"ME Flacco","year":"2022","unstructured":"Flacco ME, Acuti Martellucci C, Baccolini V, et al. COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: meta-analysis. Front Med (Lausanne). 2022;9:1023507.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"11387_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/vaccines12050464","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang M, Wei K, et al. Longitudinal analysis of humoral and cellular immune response up to 6 months after SARS-CoV-2 BA.5\/BF.7\/XBB breakthrough infection and BA.5\/BF.7-XBB reinfection. Vaccines (Basel). 2024;12(5):464.","journal-title":"Vaccines (Basel)."},{"key":"11387_CR29","doi-asserted-by":"publisher","first-page":"104903","DOI":"10.1016\/j.ebiom.2023.104903","volume":"99","author":"T Cui","year":"2024","unstructured":"Cui T, Su X, Sun J, et al. Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting. EBioMedicine. 2024;99:104903.","journal-title":"EBioMedicine"},{"issue":"26","key":"11387_CR30","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1016\/j.vaccine.2022.04.090","volume":"40","author":"L Nault","year":"2022","unstructured":"Nault L, Marchitto L, Goyette G, et al. Covid-19 vaccine immunogenicity in people living with HIV-1. Vaccine. 2022;40(26):3633\u20137.","journal-title":"Vaccine"},{"issue":"12","key":"11387_CR31","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.cmi.2021.07.031","volume":"27","author":"I Levy","year":"2021","unstructured":"Levy I, Wieder-Finesod A, Litchevsky V, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021;27(12):1851\u20135.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"11387_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1089\/vim.2022.0182","volume":"36","author":"FM Fusco","year":"2023","unstructured":"Fusco FM, Carleo MA, Sangiovanni N, et al. Does COVID-19 vaccination with BNT162b2 influence HIV-related immunological and virological markers? Data from 235 persons living with HIV at Cotugno Hospital, Naples, Italy: immune response after second and third doses, and influence on immunovirological markers. Viral Immunol. 2023;36(5):360\u20135.","journal-title":"Viral Immunol"},{"key":"11387_CR33","doi-asserted-by":"publisher","first-page":"1155855","DOI":"10.3389\/fimmu.2023.1155855","volume":"14","author":"A Aissatou","year":"2023","unstructured":"Aissatou A, Fokam J, Semengue ENJ, et al. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: a comparative analysis according to HIV-status. Front Immunol. 2023;14:1155855.","journal-title":"Front Immunol"},{"key":"11387_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939311","volume":"13","author":"Q Hua","year":"2022","unstructured":"Hua Q, Zhang H, Yao P, et al. Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 vaccine: a 6-month population-based cohort study. Front Immunol. 2022;13: 939311.","journal-title":"Front Immunol"},{"issue":"6","key":"11387_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/vaccines10060853","volume":"10","author":"T Assawasaksakul","year":"2022","unstructured":"Assawasaksakul T, Lertussavavivat T, Sathitratanacheewin S, et al. Comparison of immunogenicity and safety of inactivated, adenovirus-vectored, and heterologous adenovirus-vectored\/mRNA vaccines in patients with systemic lupus erythematosus and rheumatoid arthritis: a prospective cohort study. Vaccines (Basel). 2022;10(6):853.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"11387_CR36","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/s41467-023-40489-2","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xu N, Xu Y, et al. Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults. Nat Commun. 2023;14(1):4757.","journal-title":"Nat Commun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11387-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:05:09Z","timestamp":1757318709000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11387-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11387"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11387-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki, and approved by the Ethics Committee of Beijing Hospital (2021BJYYEC-297\u201302). An informed consent was signed prior to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"962"}}